A Placebo-Controlled Efficacy in iNPH Shunting (PENS) Trial

Go Back to All Clinical Trials

A Placebo-Controlled Efficacy in iNPH Shunting (PENS) Trial

Brief description of study

This is a multicenter, randomized, blinded, placebo-controlled study of patients with suspected idiopathic normal pressure hydrocephalus (iNPH). Using FDA-approved technology, we propose a prospective randomized placebo-controlled clinical trial for the surgical shunting treatment of iNPH. These valve systems allow a well-maintained blinded placebo control because the surgical and adjustment procedures can be entirely identical in the active and placebo groups.

Clinical Study Identifier: s22-00487

ClinicalTrials.gov Identifier: NCT05081128

Principal Investigator: David H Harter.

Other Investigators: Eveline Teresa Hidalgo, James B Golomb.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies